NCT05735015View on ClinicalTrials.gov

Study of the PTH-independent Effects of Encaleret on Mineral Homeostasis in Subjects With Postsurgical Hypoparathyroidism (PSH)

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

May 21, 2025

Study Completion Date

August 12, 2025

Conditions
Post-Surgical Hypoparathyroidism
Interventions
DRUG

encaleret

Oral administration, twice a day

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

NCT05735015 - Study of the PTH-independent Effects of Encaleret on Mineral Homeostasis in Subjects With Postsurgical Hypoparathyroidism (PSH) | Biotech Hunter | Biotech Hunter